• head_banner_01

זיהומים של חומצת אמינו המשמשת לסינתזה חלבון

תיאור קצר:

NO

מוצרים

CAS לא

1

FMOC-D-ALA-D-ALA-OH

NA

2

FMOC-ß-ALA-D-ALA-OH

NA

3

FMOC-ARG (PBF) -ARG (PBF) -OH

NA


פירוט מוצר

תגי מוצר

פירוט מוצר

NO

מוצרים

CAS לא

מחוון איכות מפתח

טוֹהַר

מקס.

טוּמאָה

שאריות ממס כוללות

לַחוּת

1

FMOC-β-ALA-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

FMOC-D-ALA-D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

FMOC-ß-ALA-D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

FMOC-ARG (PBF) -ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-ALA-ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

FMOC-D-ARG (PBF) -D-ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-ß-ALA-D-ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

Fmoc-homoarg (pbf) -homoarg (pbf) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-ß-ala-homoarg (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

FMOC-ASN (TRT) -ASN (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

FMOC-β-ALA-ASN (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

Fmoc-asp (otbu) -asp (otbu) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

FMOC-β-ALA-ASP (OTBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

Fmoc-cys (trt) -cys (trt) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

FMOC-β-ALA-CYS (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

Fmoc-cys (acm) -cys (acm) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

FMOC-β-ALA-CYS (ACM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

Fmoc-gln (trt) -gln (trt) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

FMOC-β-ALA-GLN (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

Fmoc-glu (otbu) -glu (otbu) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

FMOC-ß-ALA-Glu (OTBU) -OH.H2O

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

FMOC-ß-ala-gly-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

Fmoc-his (trt) -יו (trt) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

FMOC-ß-ala-his (trt) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

Fmoc-ile-ile-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

FMOC-β-ALA-ILE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

FMOC-LEU-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

FMOC-β-ALA-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

FMOC-D-LEU-D-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

FMOC-β-ALA-D-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

Fmoc-lys (boc) -lys (boc) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

FMOC-β-ALA-LYS (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

Fmoc-lys (alloc) -lys (alloc) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

FMOC-β-ALA-LYS (alloc) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

Fmoc-met-met-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

FMOC-ß-ala-met-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

Fmoc-orn (boc) -ורן (boc) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

FMOC-β-ALA-orn (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

FMOC-PHE-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

FMOC-β-ALA-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

FMOC-D-PHE-D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

FMOC-β-ALA-D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

Fmoc-pro-pro-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

FMOC-ß-ALA-Pro-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

FMOC-SER (TBU) -SER (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

FMOC-β-ALA-SER (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

FMOC-SER (TRT) -SER (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

FMOC-β-ALA-SER (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

Fmoc-thr (tbu) -thr (tbu) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

FMOC-β-ALA-THR (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

FMOC-TRP (BOC) -TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

FMOC-ß-ALA-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -D-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

FMOC-β-ALA-D-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

Fmoc-tyr (tbu) -tyr (tbu) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

FMOC-β-ALA-TYR (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

FMOC-D-TYR (ET) -D-TYR (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

FMOC-β-ALA-D-TYR (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

Fmoc-tyr (me) -tyr (me) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

FMOC-ß-ALA-TYR (ME) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

Fmoc-val-val-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

FMOC-ß-ALA-VAL-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

FMOC-D-CIT-D-CIT-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

FMOC-ß-ALA-D-CIT-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

FMOC-ß-ala-dab-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

Fmoc- (3- (2-naphthyl) -d-ala) 2-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

FMOC-ß-ALA-3- (2-נפתיל) -D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

Fmoc- (3- (3-pyridinyl) -d-ala) 2-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

FMOC-ß-ALA-3- (3-pyridinyl) -d-ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

FMOC- (4-כלורו-D-PHE) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

FMOC-ß-ALA-4-Chloro-D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

FMOC- (D-4APH (TBUCBM)) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

FMOC-ß-ALA-D-4APH (TBUCBM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

Fmoc-aph (l-hor) -aph (l-hor) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

FMOC-β-ALA-APH (l-HOR) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

Fmoc-lys (ipr, boc) -lys (ipr, boc) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

FMOC-β-ALA-LYS (IPR, BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

FMOC-ß-ALA-AEEA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

FMOC-AIB-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

FMOC-ß-ALA-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

FMOC-ARG-OH

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-ARG (PBF) -OH

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

Fmoc-d-arg-oh

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

HD-ARG (PBF) -OH

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

Fmoc-homoarg-oh.hcl

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-HOMOARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

Fmoc-d-homoarg-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

HD-HOMOARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

FMOC-ASN-OH

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-ASN (TRT) -OH

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

FMOC-ASP-OH

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-asp (otbu) -OH

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

Fmoc-cys-oh

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-Cys (TRT) -OH

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-CYS (ACM) -OH.HCL

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

FMOC-GLN-OH

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-Gln (Trt) -OH

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

Fmoc-glu-oh

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-glu (otbu) -OH.H2O

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

Fmoc-his-oh

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-his (trt) -OH

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

Boc-his-oh

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

FMOC-LYS-OH

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-lys (Boc) -OH

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-lys (alloc) -OH

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

Fmoc-orn-oh.hcl

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

H-orn (BOC) -OH

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

Fmoc-ser-oh

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-Ser (TBU) -OH

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-Ser (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

Fmoc-thr-oh.h2o

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-thr (tbu) -OH

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

FMOC-TRP-OH

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-TRP (BOC) -OH

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

FMOC-D-TRP-OH

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

HD-TRP (BOC) -OH

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

Fmoc-tyr-oh

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-tyr (TBU) -OH

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

Fmoc-d-tyr-oh

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

HD-Tyr (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-tyr (ME) -OH.HCL

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

FMOC-D-4APH (CBM) -OH

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

HD-4APH (TBUCBM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

FMOC-LYS (IPR) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-LYS (IPR, BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

אוֹדוֹת

פיצוי

Gentolex מספקת מוצרים באיכות מעולה, אם איכות מוצר כלשהי מוגברת על ידי הלקוח במסגרת הזמן הנדרשת עם עדויות מספקות, אנו נספק ניתוח והערכה נחוצים כדי להפעיל את נהלי הפיצויים.

הֲפָקָה

היכולות של מוצרי תרופות הגיעו לדרגת טונות, יכולותיהם של מוצרים כימיים מגיעים ל 100 טונים+ כיתה, היכולות מצוידות היטב לשרת לקוחות ברחבי העולם.

מחקר ופיתוח

בכל שנה יש תוכנית שהוקמה על ידי צוות המו"פ לפיתוח מוצרים חדשים שונים, כאשר יעדים מוגדרים, כל חבר בצוות יצטרך להמשיך באחריות KPI ובמדיניות תמריצים.


  • קוֹדֵם:
  • הַבָּא:

  • כתוב את ההודעה שלך כאן ושלח אלינו